Cost-Effectiveness of Blood Glucose Monitoring Is Controversial

TO THE EDITORS

:

VA Center for Medication Safety, Hines VA

Center for Health Equity Research and Promotion, VA

School of Pharmacy

VA Greater Los Angeles Healthcare System

Los Angeles, California

Funding: None reported.

Author Disclosure: The authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.

Address correspondence to: Sherrie L. Aspinall, PharmD, MSc, VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion (151C-H), 7180 Highland Dr, Pittsburgh, PA 15206. E-mail: sherrie.aspinall@med.va.gov.

References

2. Karter AJ, Parker MM, Moffet HH, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care. 2006;29(8):1757-1763.

4. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005;118(4):422-425.

IN REPLY

:

Health Economics and Outcomes Research

Noblesville, IN

Funding: LifeScan, A Johnson and Johnson Company.

Author Disclosures: The authors (SLT, MEM) are employees of IMS, a company that provides contracted research consulting to LifeScan.

Address correspondence to: Sandra L. Tunis, PhD, Health Economics and Outcomes Research, IMS Consulting Services, 14701 Cumberland Rd, Ste 107, Nobelsville, IN 46060. E-mail: stunis@us.imshealth.com.

1.Tunis SL, Minshall ME. Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the United States. Am J Manag Care. 2008;14(3):131-140.

3. Centers for Disease Control and Prevention, National Center for Health Statistics. National Nutrition and Health Examination Survey (NHANES) data. Hyattsville, MD: US Department of Health and Human Services; 2000.

Download PDF: Cost-Effectiveness of Blood Glucose Monitoring Is Controversial